ArticleEnvironment systems & decisions2018
Comparative, collaborative, and integrative risk governance for emerging technologies.
Article in Environment systems & decisions, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed.
- Applying the Bow Tie Method to Evaluate Emerging Risk: The Case of Carbon Capture and Water Stress.Risk analysis : an official publication of the Society for Risk Analysis · 2026Article
- Navigating the human gene editing scene and proposing a new governance framework in Africa: from knowledge to policy to action.Frontiers in genome editing · 2026Article
- The whack-a-mole governance challenge for AI-enabled synthetic biology: literature review and emerging frameworks.Frontiers in bioengineering and biotechnology · 2024Review
- The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics · 2024Article
- U. S. federal perspective on critical research issues in nanoEHS.Environmental science. Nano · 2023Article
- Exploring the Impact of Tensions in Stakeholder Norms on Designing for Value Change: The Case of Biosafety in Industrial Biotechnology.Science and engineering ethics · 2023Article
- (Re)Conceptualizing decision-making tools in a risk governance framework for emerging technologies-the case of nanomaterials.Environment systems & decisions · 2023Review
- Bridging international approaches on nanoEHS.Nature nanotechnology · 2021Article
- Responsible Learning About Risks Arising from Emerging Biotechnologies.Science and engineering ethics · 2021Article
- Safe-by-Design: Stakeholders' Perceptions and Expectations of How to Deal with Uncertain Risks of Emerging Biotechnologies in the Netherlands.Risk analysis : an official publication of the Society for Risk Analysis · 2020Article
- Building biosecurity for synthetic biology.Molecular systems biology · 2020Article
- Risk Perceptions and Safety Cultures in the Handling of Nanomaterials in Academia and Industry.Annals of work exposures and health · 2020Article
- AMICAI: A Method Based on Risk Analysis to Integrate Responsible Research and Innovation into the Work of Research and Innovation Practitioners.Science and engineering ethics · 2020Article
- Workshop Report: Governance of Emerging Nanotechnology Risks in the Semiconductor Industry.Frontiers in public health · 2020Article
- Article
- Best practices from nano-risk analysis relevant for other emerging technologies.Nature nanotechnology · 2019Article
- A Definition and Categorization System for Advanced Materials: The Foundation for Risk-Informed Environmental Health and Safety Testing.Risk analysis : an official publication of the Society for Risk Analysis · 2019Article
- Risk Governance of Nanomaterials: Review of Criteria and Tools for Risk Communication, Evaluation, and Mitigation.Nanomaterials (Basel, Switzerland) · 2019Article
- Article
- An inventory of ready-to-use and publicly available tools for the safety assessment of nanomaterials.NanoImpact · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
25 authors.
Funding
Abstract
Various emerging technologies challenge existing governance processes to identify, assess, and manage risk. Though the existing risk-based paradigm has been essential for assessment of many chemical, biological, radiological, and nuclear technologies, a complementary approach may be warranted for the early-stage assessment and management challenges of high uncertainty technologies ranging from nanotechnology to synthetic biology to artificial intelligence, among many others. This paper argues for a risk governance approach that integrates quantitative experimental information alongside qualitative expert insight to characterize and balance the risks, benefits, costs, and societal implications of emerging technologies. Various articles in scholarly literature have highlighted differing points of how to address technological uncertainty, and this article builds upon such knowledge to explain how an emerging technology risk governance process should be driven by a multi-stakeholder effort, incorporate various disparate sources of information, review various endpoints and outcomes, and comparatively assess emerging technology performance against existing conventional products in a given application area. At least in the early stages of development when quantitative data for risk assessment remain incomplete or limited, such an approach can be valuable for policymakers and decision makers to evaluate the impact that such technologies may have upon human and environmental health.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.